1,458 research outputs found
Effective Conformal Theory and the Flat-Space Limit of AdS
We develop the idea of an effective conformal theory describing the low-lying
spectrum of the dilatation operator in a CFT. Such an effective theory is
useful when the spectrum contains a hierarchy in the dimension of operators,
and a small parameter whose role is similar to that of 1/N in a large N gauge
theory. These criteria insure that there is a regime where the dilatation
operator is modified perturbatively. Global AdS is the natural framework for
perturbations of the dilatation operator respecting conformal invariance, much
as Minkowski space naturally describes Lorentz invariant perturbations of the
Hamiltonian. Assuming that the lowest-dimension single-trace operator is a
scalar, O, we consider the anomalous dimensions, gamma(n,l), of the
double-trace operators of the form O (del^2)^n (del)^l O. Purely from the CFT
we find that perturbative unitarity places a bound on these dimensions of
|gamma(n,l)|<4. Non-renormalizable AdS interactions lead to violations of the
bound at large values of n. We also consider the case that these interactions
are generated by integrating out a heavy scalar field in AdS. We show that the
presence of the heavy field "unitarizes" the growth in the anomalous
dimensions, and leads to a resonance-like behavior in gamma(n,l) when n is
close to the dimension of the CFT operator dual to the heavy field. Finally, we
demonstrate that bulk flat-space S-matrix elements can be extracted from the
large n behavior of the anomalous dimensions. This leads to a direct connection
between the spectrum of anomalous dimensions in d-dimensional CFTs and
flat-space S-matrix elements in d+1 dimensions. We comment on the emergence of
flat-space locality from the CFT perspective.Comment: 46 pages, 2 figures. v2: JHEP published versio
Spin-valley phase diagram of the two-dimensional metal-insulator transition
Using symmetry breaking strain to tune the valley occupation of a
two-dimensional (2D) electron system in an AlAs quantum well, together with an
applied in-plane magnetic field to tune the spin polarization, we independently
control the system's valley and spin degrees of freedom and map out a
spin-valley phase diagram for the 2D metal-insulator transition. The insulating
phase occurs in the quadrant where the system is both spin- and
valley-polarized. This observation establishes the equivalent roles of spin and
valley degrees of freedom in the 2D metal-insulator transition.Comment: 4 pages, 2 figure
Oncological considerations of skin-sparing mastectomy
AIM: To review evidence concerning the oncological safety of performing skin-sparing mastectomy (SSM) for invasive breast cancer and ductal carcinoma in situ (DCIS). Furthermore, the evidence concerning RT in relation to SSM and the possibility of nipple preservation was considered. METHODS: Literature review facilitated by Medline and PubMed databases. FINDINGS: Despite the lack of randomised controlled trials, SSM has become an accepted procedure in women undergoing mastectomy and immediate reconstruction for early breast cancer. Compared to non-skin-sparing mastectomy (NSSM), SSM seems to be oncologically safe in patients undergoing mastectomy for invasive tumours smaller than 5 cm, multicentric tumours, DCIS or risk-reduction. However, the technique should be avoided in patients with inflammatory breast cancer or in those with extensive tumour involvement of the skin in view of the high risk of local recurrence. SSM with nipple areola complex (NAC) preservation appears to be oncologically safe, provided the tumour is not close to the nipple and a frozen section protocol for the retro-areolar tissue is followed. Although radiotherapy (RT) does not represent a contraindication to SSM, the latter should be used with caution if postoperative RT is likely, since it detracts from the final cosmetic outcome
The Evolution of Bat Vestibular Systems in the Face of Potential Antagonistic Selection Pressures for Flight and Echolocation
PMCID: PMC3634842This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
The science of clinical practice: disease diagnosis or patient prognosis? Evidence about "what is likely to happen" should shape clinical practice.
BACKGROUND: Diagnosis is the traditional basis for decision-making in clinical practice. Evidence is often lacking about future benefits and harms of these decisions for patients diagnosed with and without disease. We propose that a model of clinical practice focused on patient prognosis and predicting the likelihood of future outcomes may be more useful. DISCUSSION: Disease diagnosis can provide crucial information for clinical decisions that influence outcome in serious acute illness. However, the central role of diagnosis in clinical practice is challenged by evidence that it does not always benefit patients and that factors other than disease are important in determining patient outcome. The concept of disease as a dichotomous 'yes' or 'no' is challenged by the frequent use of diagnostic indicators with continuous distributions, such as blood sugar, which are better understood as contributing information about the probability of a patient's future outcome. Moreover, many illnesses, such as chronic fatigue, cannot usefully be labelled from a disease-diagnosis perspective. In such cases, a prognostic model provides an alternative framework for clinical practice that extends beyond disease and diagnosis and incorporates a wide range of information to predict future patient outcomes and to guide decisions to improve them. Such information embraces non-disease factors and genetic and other biomarkers which influence outcome. SUMMARY: Patient prognosis can provide the framework for modern clinical practice to integrate information from the expanding biological, social, and clinical database for more effective and efficient care
Emergence of the Asian 1 Genotype of Dengue Virus Serotype 2 in Viet Nam: In Vivo Fitness Advantage and Lineage Replacement in South-East Asia
A better description of the extent and structure of genetic diversity in dengue virus (DENV) in endemic settings is central to its eventual control. To this end we determined the complete coding region sequence of 187 DENV-2 genomes and 68 E genes from viruses sampled from Vietnamese patients between 1995 and 2009. Strikingly, an episode of genotype replacement was observed, with Asian 1 lineage viruses entirely displacing the previously dominant Asian/American lineage viruses. This genotype replacement event also seems to have occurred within DENV-2 in Thailand and Cambodia, suggestive of a major difference in viral fitness. To determine the cause of this major evolutionary event we compared both the infectivity of the Asian 1 and Asian/American genotypes in mosquitoes and their viraemia levels in humans. Although there was little difference in infectivity in mosquitoes, we observed significantly higher plasma viraemia levels in paediatric patients infected with Asian 1 lineage viruses relative to Asian/American viruses, a phenotype that is predicted to result in a higher probability of human-to-mosquito transmission. These results provide a mechanistic basis to a marked change in the genetic structure of DENV-2 and more broadly underscore that an understanding of DENV evolutionary dynamics can inform the development of vaccines and anti-viral drugs
Superconformal Flavor Simplified
A simple explanation of the flavor hierarchies can arise if matter fields
interact with a conformal sector and different generations have different
anomalous dimensions under the CFT. However, in the original study by Nelson
and Strassler many supersymmetric models of this type were considered to be
'incalculable' because the R-charges were not sufficiently constrained by the
superpotential. We point out that nearly all such models are calculable with
the use of a-maximization. Utilizing this, we construct the simplest
vector-like flavor models and discuss their viability. A significant constraint
on these models comes from requiring that the visible gauge couplings remain
perturbative throughout the conformal window needed to generate the
hierarchies. However, we find that there is a small class of simple flavor
models that can evade this bound.Comment: 43 pages, 1 figure; V3: small corrections and clarifications,
references adde
Bounds on 4D Conformal and Superconformal Field Theories
We derive general bounds on operator dimensions, central charges, and OPE
coefficients in 4D conformal and N=1 superconformal field theories. In any CFT
containing a scalar primary phi of dimension d we show that crossing symmetry
of implies a completely general lower bound on the central
charge c >= f_c(d). Similarly, in CFTs containing a complex scalar charged
under global symmetries, we bound a combination of symmetry current two-point
function coefficients tau^{IJ} and flavor charges. We extend these bounds to
N=1 superconformal theories by deriving the superconformal block expansions for
four-point functions of a chiral superfield Phi and its conjugate. In this case
we derive bounds on the OPE coefficients of scalar operators appearing in the
Phi x Phi* OPE, and show that there is an upper bound on the dimension of Phi*
Phi when dim(Phi) is close to 1. We also present even more stringent bounds on
c and tau^{IJ}. In supersymmetric gauge theories believed to flow to
superconformal fixed points one can use anomaly matching to explicitly check
whether these bounds are satisfied.Comment: 47 pages, 9 figures; V2: small corrections and clarification
Subcutaneous dissociative conscious sedation (sDCS) an alternative method for airway regional blocks: a new approach
<p>Abstract</p> <p>Background</p> <p>Predicted difficult airway is a definite indication for awake intubation and spontaneous ventilation. Airway regional blocks which are commonly used to facilitate awake intubation are sometimes impossible or forbidden. On the other hand deep sedation could be life threatening in the case of compromised airway.</p> <p>The aim of this study is evaluating "Subcutaneous Dissociative Conscious Sedation" (sDCS) as an alternative method to airway regional blocks for awake intubation.</p> <p>Methods</p> <p>In this prospective, non-randomized study, 30 patients with predicted difficult airway (laryngeal tumors), who were scheduled for direct laryngoscopic biopsy (DLB), underwent "Subcutaneous Dissociative Conscious Sedation" (sDCS) exerted by intravenous fentanyl 3-4ug/kg and subcutaneous ketamine 0.6-0.7 mg/kg. The tongue and pharynx were anesthetized with lidocaine spray (4%<b>)</b>. 10 minutes after a subcutaneous injection of ketamine direct laryngoscopy was performed. Extra doses of fentanyl 50-100 ug were administered if the patient wasn't cooperative enough for laryngoscopy.</p> <p>Patients were evaluated for hemodynamic stability (heart rate and blood pressure), oxygen saturation (Spo<sub>2</sub>), patient cooperation (obedient to open the mouth for laryngoscopy and the number of tries for laryngoscopy), patient comfort (remaining moveless), hallucination, nystagmus and salivation (need for aspiration before laryngoscopy).</p> <p>Results</p> <p>Direct laryngoscopy was performed successfully in all patients. One patient needed extra fentanyl and then laryngoscopy was performed successfully on the second try. All patients were cooperative enough during laryngoscopy. Hemodynamic changes more than 20% occurred in just one patient. Oxygen desaturation (spo<sub>2</sub>< 90%) didn't occur in any patient.</p> <p>Conclusions</p> <p>Subcutaneous Dissociative Conscious Sedation (sDCS) as a new approach to airway is an acceptable and safe method for awake intubation and it can be suggested as a noninvasive substitute of low complication rate for regional airway blocks.</p> <p>Registration ID in IRCT</p> <p>IRCT201012075333N1</p
A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
There is no available drug or vaccine against dengue, an acute viral disease that affects ∼50 million people annually in tropical and sub-tropical countries. Chloroquine (CQ), a cheap and well-tolerated drug, inhibits the growth of dengue viruses in the laboratory with concentrations achievable in the body. To measure the antiviral efficacy of CQ in dengue, we conducted a study involving 307 adults with suspected dengue. Patients received a 3-day oral dosage of placebo or CQ early in their illness. Unfortunately, we did not see an effect of CQ on the duration of viral infection. We did, however, observe that CQ had a modest anti-fever effect. In patients treated with CQ, we observed a trend towards a lower incidence of dengue hemorrhagic fever, a severe form of dengue. We did not find any differences in the immune response that can explain this trend. We also found more adverse events, primarily vomiting, with CQ. This trial provides valuable new information on how to perform trials of antiviral drugs for dengue
- …